Published in Part Fibre Toxicol on March 07, 2015
Cationic Polyamidoamine Dendrimers as Modulators of EGFR Signaling In Vitro and In Vivo. PLoS One (2015) 0.78
Tolerogenic Nanoparticles to Treat Islet Autoimmunity. Curr Diab Rep (2017) 0.75
Toxic potential of materials at the nanolevel. Science (2006) 19.24
Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature (2002) 5.02
Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res (2005) 4.71
Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma. Eur Respir J (2009) 4.54
Dendrimers in biomedical applications--reflections on the field. Adv Drug Deliv Rev (2005) 3.39
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med (2005) 3.26
Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature (2005) 3.09
Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J Intern Med (2010) 2.57
Dendrimer biocompatibility and toxicity. Adv Drug Deliv Rev (2005) 2.56
PAMAM nanoparticles promote acute lung injury by inducing autophagic cell death through the Akt-TSC2-mTOR signaling pathway. J Mol Cell Biol (2009) 2.00
Nanoparticles for drug delivery to the lungs. Trends Biotechnol (2007) 1.73
Reducing infections through nanotechnology and nanoparticles. Int J Nanomedicine (2011) 1.72
Pulmonary injury induced by C3a and C5a anaphylatoxins. Am J Pathol (1980) 1.48
Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability. Bioconjug Chem (2007) 1.36
Nanotoxicology and nanoparticle safety in biomedical designs. Int J Nanomedicine (2011) 1.25
Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticles. Nanotoxicology (2011) 1.17
Systemic administration of combinatorial dsiRNAs via nanoparticles efficiently suppresses HIV-1 infection in humanized mice. Mol Ther (2011) 1.16
Immortalization of human alveolar epithelial cells to investigate nanoparticle uptake. Am J Respir Cell Mol Biol (2008) 1.13
Toxicity assessment of zinc oxide nanoparticles using sub-acute and sub-chronic murine inhalation models. Part Fibre Toxicol (2014) 1.10
3H dendrimer nanoparticle organ/tumor distribution. Pharm Res (2004) 1.08
A functionalized single-walled carbon nanotube-induced autophagic cell death in human lung cells through Akt-TSC2-mTOR signaling. Cell Death Dis (2011) 1.07
Engineered nanomaterials: exposures, hazards, and risk prevention. J Occup Med Toxicol (2011) 1.05
Dendrimers as a carrier for pulmonary delivery of enoxaparin, a low-molecular weight heparin. J Pharm Sci (2007) 1.02
Evidence for an intrinsic angiotensin system in the canine pancreas. J Hypertens (1991) 0.99
Cationic PAMAM dendrimers aggressively initiate blood clot formation. ACS Nano (2012) 0.99
Effects of inhaled nanoparticles on acute lung injury induced by lipopolysaccharide in mice. Toxicology (2007) 0.95
Copper oxide nanoparticles induce autophagic cell death in A549 cells. PLoS One (2012) 0.94
Unexpected in vivo anti-inflammatory activity observed for simple, surface functionalized poly(amidoamine) dendrimers. Biomacromolecules (2009) 0.94
Charge affects the oral toxicity of poly(amidoamine) dendrimers. Eur J Pharm Biopharm (2013) 0.93
G3.5 PAMAM dendrimers enhance transepithelial transport of SN38 while minimizing gastrointestinal toxicity. J Control Release (2010) 0.93
Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections. Nat Commun (2014) 0.92
Cationic PAMAM dendrimers disrupt key platelet functions. Mol Pharm (2012) 0.90
Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients. Nat Commun (2014) 0.90
Comparative toxicological assessment of PAMAM and thiophosphoryl dendrimers using embryonic zebrafish. Int J Nanomedicine (2014) 0.89
Consumer products leap aboard the nano bandwagon. Nature (2006) 0.87
Intravascular and endobronchial DNA delivery to murine lung tissue using a novel, nonviral vector. Hum Gene Ther (2000) 0.86
Mitochondrial KATP channel involvement in angiotensin II-induced autophagy in vascular smooth muscle cells. Basic Res Cardiol (2014) 0.86
Do nanomedicines require novel safety assessments to ensure their safety for long-term human use? Drug Saf (2009) 0.85
Angiotensin-converting enzyme in developing lung and kidney. Am J Physiol (1978) 0.85
Effects of acute lung injury on dynamic tissue properties. J Appl Physiol (1985) (1994) 0.84
Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury. Sci Rep (2014) 0.81
Dendrimer research. Science (1991) 0.80
PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization. Int J Pharm (2013) 0.77
Acute lung injury: a yellow card for engineered nanoparticles? J Mol Cell Biol (2009) 0.77
Effects of pulmonary vascular recruitment on gamma scintigraphy and pulmonary capillary protein leak. Surgery (1981) 0.76
Attenuation of β-Amyloid Toxicity In Vitro and In Vivo by Accelerated Aggregation. Neurosci Bull (2017) 0.75